Status:
COMPLETED
Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the CM-1500
Lead Sponsor:
Zynex Monitoring Solutions
Conditions:
Fluid Loss
Blood Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is a prospective, non-randomized, non-blinded, non-significant risk study enrolling up to 60 healthy adult subjects consented to undergo a 1-unit whole blood draw procedure. Subjects will we...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent
- Ability and willingness to comply with the study procedures and duration requirements
- 18 years of age or older
- Consented and eligible to undergo a single unit whole blood donation
Exclusion
- Females who are pregnant or breastfeeding
- Undergone an amputation of any upper extremity
- Diagnosed with dextrocardia
- Subjects who have a pacemaker
- Subjects with body hair density which prevents adequate application of device electrodes
Key Trial Info
Start Date :
August 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05980013
Start Date
August 28 2023
End Date
April 10 2024
Last Update
May 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Vitalant Research Institute
Denver, Colorado, United States, 80230
2
SunCoast Blood Centers
Bradenton, Florida, United States, 34211